C&CURE & ADVANCEMENTS
Cure & Advancements/November 12, 2026/2 min read

ISX-9: A Step Forward in Growing Insulin-Producing Cells from Stem Cells

Researchers have identified a compound that improves the development of beta-like cells from stem cells—a key step toward potentially restoring the body's own insulin production in Type 1 diabetes.

Research summaryPubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cure researchbeta cellsimmunotherapyadvancements

Key takeaways

  • ISX-9 helps expand the specific pancreatic cells needed to create functioning beta cells from stem cells
  • This advancement could improve the yield and function of lab-grown islets for transplantation
  • The research reveals how signaling between cells and their surrounding matrix influences which cells become beta cells
  • This work is part of ongoing efforts to develop cell replacement therapies for Type 1 diabetes

Why Growing Beta Cells Matters

Type 1 diabetes occurs when the body's insulin-producing beta cells are lost or destroyed. Scientists have long explored whether stem cell-derived islets—insulin-producing tissue grown in the lab—could restore the body's ability to make its own insulin. This approach differs from current insulin replacement therapy and could potentially transform how Type 1 diabetes is managed.

The challenge has been making enough functional beta cells efficiently. A new study published in Developmental Cell offers progress on this frontier.

What ISX-9 Does

Researchers led by Zhao and Liang found that a compound called ISX-9 improves the process of converting stem cells into beta cells. Specifically, ISX-9 expands PDX1+/NKX6-1+ pancreatic progenitors—intermediate cells that are specialized to become beta cells.

By improving this expansion, ISX-9 increases both the number of beta-like cells that can be generated and their function, meaning they work more like natural insulin-producing cells.

Understanding How Cells Know What to Become

Beyond ISX-9's direct effects, the research revealed something important about cell development: how cells interact with their surrounding environment—specifically the extracellular matrix—influences whether they become beta cells. This insight could guide future efforts to improve stem cell differentiation.

These findings add to our understanding of the signals and conditions needed to guide stem cells reliably toward becoming functional insulin-producing tissue.

What Comes Next

This work represents a step forward in the lab toward developing stem cell-derived islet transplants. However, significant research and development remain before this approach could reach patients. Future work will need to confirm these results, optimize the process further, and test safety and effectiveness in clinical settings.

For people with Type 1 diabetes and their families, this kind of research keeps alive the possibility of therapies that restore the body's natural insulin production—an active area of scientific development.

Evidence label

Source: Developmental cell. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

From Type1Cure

Our own writing on the same ground.

More evidence-labeled coverage across the Type1Cure library.